Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide Scintigraphy Study in Postmenopausal Osteoporosis
NCT00259298Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2005
- Primary completion
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Nov 2005; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00259298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259298.